Siegfried Holding
Update in progressSFZN.SW (Swiss)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
Siegfried Holding AG, with its subsidiaries, focuses on contract development and manufacturing of active pharmaceutical ingredients (APIs) and finished dosage forms worldwide. It offers custom API synthesis, a broad API portfolio (exclusive and non-exclusive), and pharma-grade substances for anesthetics, pain and addiction, CNS, respiratory, and caffeine-related uses. It also provides drug products (sterile fill/finish, ophthalmics, inhalation, oral solids), viral vectors, and tech services in chemistry, analytics, formulation, containment, and cell/gene therapies. Founded 1873; based in Zofingen, Switzerland.
Company score
- Sentiment
- 0.25
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.00
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.13
- Governance
- 0.07
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.05
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.15
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Company
- MarketSwiss (EBS)
- LocationSwitzerland
- CEOMr. Marcel Imwinkelried
- Founded1873
- Employees4,454
- Websitewww.siegfried.ch
Identifiers
- ISINCH0014284498
- FIGIBBG000BC8YB5
- LEI506700J9QD6IF3937W06